The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Mary Devlin Capizzi
Advertisement
Mary Devlin Capizzi is partner, Faegre Drinker Biddle & Reath LLP.
Articles by Mary Devlin Capizzi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
2
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
3
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
4
Biomarker Testing Gaps Can Stall Targeted Oncology Therapy, BMS’s Dr Pennell Says
5